ReviewSe pu = Chinese journal of chromatography2022
[Advances in chiral separation and analysis by capillary electrophoresis-mass spectrometry].
Review in Se pu = Chinese journal of chromatography, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Metabolomics-Driven Precision Prevention and Treatment of Heart Failure with Traditional Chinese Medicine: From Mechanistic Insights to Metabolic Network Regulation.Drug design, development and therapy · 2026Review
- Development and application of chiral separation technology based on chiral metal-organic frameworks.Journal of pharmaceutical analysis · 2025Review
- Progress in Transcriptomics and Metabolomics in Plant Responses to Abiotic Stresses.Current issues in molecular biology · 2025Review
- [Highly sensitive detection of fluorescent whitening agents in flour using sheathless capillary electrophoresis-electrospray ionization-tandem mass spectrometry].Se pu = Chinese journal of chromatography · 2024Article
- [Recent developments in the application of covalent organic frameworks in capillary electrochromatography].Se pu = Chinese journal of chromatography · 2023Article
- [Annual review of capillary electrophoresis technology in 2022].Se pu = Chinese journal of chromatography · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most drugs used to treat diseases are chiral compounds. Drug enantiomers possess similar physical and chemical properties but may feature distinct pharmacological activities. Drug enantiomers may also exhibit different or even opposite functionalities for metabolism, in terms of the metabolic rate and toxicity in the body. Therefore, it is imperative to analyze, separate, and purify the enantiomers of drugs. The separation of chiral compounds is essential for drug research and development. It is also of significance in various fields including biological environments, food, and medicine. Various highly selective and sensitive methods have been developed for the quantitative and qualitative analyses of chiral compounds. A typically employed technique is high performance liquid chromatography-mass spectrometry (HPLC-MS). While HPLC-MS offers high sensitivity and reproducibility, it requires expensive chiral columns and MS-compatible mobile phases for the chromatographic column. Further, the column efficiency and resolution capacity in chiral chromatography packing require improvement. Recent progress has shown that capillary electrophoresis-mass spectrometry (CE-MS) has broad applications in chiral analysis. As a well-established analytical technique, CE-MS combines the highly efficient separation technique of CE with the highly sensitive detection technique of MS. Thus, it offers many essential advantages for analysis. For example, CE-MS has a high separation efficiency and requires very low amounts of samples and reagents. It can also achieve sensitive and selective determination, and the obtained diversified separation modes can be used for different samples. Therefore, CE-MS has proved to be important in analytical chemistry, especially in proteomics and metabolomics. CE can also exhibit excellent performance in chiral separation. Hence, combined with the sensitive detection technique of MS, CE-MS would be ideal for chiral analysis. Chiral CE-MS can provide a wide range of qualitative information on samples simultaneously in a single run, including the migration time, relative molecular mass, and ionic fragments. It addresses the challenges associated with identifying unknown chiral compounds in actual samples (including chiral compounds without UV absorption groups or fluorescence groups). The high-throughput analysis of multiple groups of chiral enantiomers can be achieved while mitigating the matrix effect of biological samples. In the last ten years, high performance chiral analysis strategies based on different CE-MS modes have been developed. These include electrokinetic chromatography-mass spectrometry (EKC-MS), micellar electrokinetic chromatography-mass spectrometry (MEKC-MS), and capillary electrochromatography-mass spectrometry (CEC-MS). CE-MS has been successfully applied in chiral analysis in various fields such as medicine, biology, food, and environmental science. CE-MS is promising in the chiral analysis of drugs, especially for drug development and drug quality control, as well as pharmacokinetics and pharmacodynamics research. Recent studies have focused on the development of MS-friendly and highly selective chiral analytical methods, which will broaden the application of CE-MS. In CEC-MS chiral analysis, more attention has been paid to developing novel capillary chiral stationary phases for monolithic or packed columns. Because of the diversity of chiral selectors for EKC-MS and MEKC-MS, the chiral analysis of drugs using these techniques has attracted intense research interest. Moreover, functional nanoparticles have been employed to increase the surface area of the CEC columns for enhancing the efficiency of chiral analysis. The chiral separation and analysis of miniaturized microchip equipment via CE-MS has also been explored, but remains to be widely used in practical applications. The purpose of this review is to provide insights that would aid in broadening the applications of CE-MS to chiral analysis. In this review, we primarily summarize research progress on the application of CE-MS to chiral analysis, based on the literature published during the years 2011-2021. Chiral selectors (e. g., modified cyclodextrin and polymer surfactants) and their reported applications in CE-MS are presented. The determination results for drug enantiomers using different CE-MS modes are compared. The application of CE-MS in other research fields is also presented, along with the advantages and limitations of different CE-MS methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.